EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische Studie

Diagnostic Value of Clear Cell Likelihood Score v1.0 and v2.0 for Common Subtypes of Small Renal Masses: A Multicenter Comparative Study

Yu-Wei Hao iD, Xue-Yi Ning, He Wang, Xu Bai iD, Jian Zhao, Wei Xu, Xiao-Jing Zhang, Da-Wei Yang iD, Jia-Hui Jiang iD, Xiao-Hui Ding, Meng-Qiu Cui, Bai-Chuan Liu und 3 weitere

Journal of Magnetic Resonance Imaging · 2025

DOI: 10.1002/jmri.29392 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Magnetic Resonance Imaging, 2025. Verfasst von Yu-Wei Hao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, First Medical Center, Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Algorithms, Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: The National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clear cell likelihood score (ccLS) is reliable for diagnosing small renal masses (SRMs). However, the diagnostic value of Clear cell likelihood score version 1.0 (ccLS v1.0) and v2.0 for common subtypes of SRMs might be a potential score extension.

Purpose

To compare the diagnostic performance and interobserver agreement of ccLS v1.0 and v2.0 for characterizing five common subtypes of SRMs. Study Type Retrospective. Population 797 patients (563 males, 234 females; mean age, 53 ± 12 years) with 867 histologically proven renal masses. Field Strength/Sequences 3.0 and 1.5 T/T2 weighted imaging, T1 weighted imaging, diffusion‐weighted imaging, a dual‐echo chemical shift (in‐ and opposed‐phase) T1 weighted imaging, multiphase dynamic contrast‐enhanced imaging. Assessment Six abdominal radiologists were trained in the ccLS algorithm and independently scored each SRM using ccLS v1.0 and v2.0, respectively. All SRMs had definite pathological results. The pooled area under curve (AUC), accuracy, sensitivity, and specificity were calculated to evaluate the diagnostic performance of ccLS v1.0 and v2.0 for characterizing common subtypes of SRMs. The average κ values were calculated to evaluate the interobserver agreement of the two scoring versions. Statistical Tests Random‐effects logistic regression; Receiver operating characteristic analysis; DeLong test; Weighted Kappa test; Z test. The statistical significance level was P < 0.05.

Results

The pooled AUCs of clear cell likelihood score version 2.0 (ccLS v2.0) were statistically superior to those of ccLS v1.0 for diagnosing clear cell renal cell carcinoma (ccRCC) (0.907 vs. 0.851), papillary renal cell carcinoma (pRCC) (0.926 vs. 0.888), renal oncocytoma (RO) (0.745 vs. 0.679), and angiomyolipoma without visible fat (AMLwvf) (0.826 vs. 0.766). Interobserver agreement for SRMs between ccLS v1.0 and v2.0 is comparable and was not statistically significant ( P = 0.993).

Conclusion

The diagnostic performance of ccLS v2.0 surpasses that of ccLS v1.0 for characterizing ccRCC, pRCC, RO, and AMLwvf. Especially, the standardized algorithm has optimal performance for ccRCC and pRCC. ccLS has potential as a supportive clinical tool. Evidence Level 4. Technical Efficacy Stage 2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlgorithmsCarcinoma, Renal CellKidney NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedContrast MediaKidneyMagnetic Resonance ImagingObserver VariationReproducibility of ResultsRetrospective StudiesSensitivity and Specificity

Stichwörter der Autor:innen

clear cell likelihood scoremagnetic resonance imagingsmall renal masses

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Radiology, First Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Department of Radiology, Sixth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Department of Radiology, Peking University First Hospital, Beijing, China.
  • Department of Radiology, Fifth Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Department of Radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Department of Pathology, First Medical Center, Chinese PLA General Hospital, Beijing, China.

ORCID-Profile: Yu-Wei Hao, Xu Bai, Da-Wei Yang, Jia-Hui Jiang, Hai-Yi Wang

Förderung

  • The National Natural Science Foundation of China
  • Beijing Municipal Natural Science Foundation
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Hao, Y. W., Ning, X. Y., Wang, H., Bai, X., Zhao, J., Xu, W., Zhang, X. J., Yang, D. W., Jiang, J. H., Ding, X. H., Cui, M. Q., Liu, B. C., Guo, H. P., Ye, H. Y., & Wang, H. Y. (2025). Diagnostic Value of Clear Cell Likelihood Score v1.0 and v2.0 for Common Subtypes of Small Renal Masses: A Multicenter Comparative Study. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29392

Vancouver

Hao YW, Ning XY, Wang H, Bai X, Zhao J, Xu W, et al. Diagnostic Value of Clear Cell Likelihood Score v1.0 and v2.0 for Common Subtypes of Small Renal Masses: A Multicenter Comparative Study. Journal of Magnetic Resonance Imaging. 2025. doi:10.1002/jmri.29392

BibTeX
@article{Hao2025,
  author = {Hao, Yu-Wei and Ning, Xue-Yi and Wang, He and Bai, Xu and Zhao, Jian and Xu, Wei and Zhang, Xiao-Jing and Yang, Da-Wei and Jiang, Jia-Hui and Ding, Xiao-Hui and Cui, Meng-Qiu and Liu, Bai-Chuan and Guo, Hui-Ping and Ye, Hui-Yi and Wang, Hai-Yi},
  title = {Diagnostic Value of Clear Cell Likelihood Score v1.0 and v2.0 for Common Subtypes of Small Renal Masses: A Multicenter Comparative Study},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2025},
  doi = {10.1002/jmri.29392}
}
Kostenlos starten →